Inflammation Supplement Market - 2025-2033

April 2026 | 207 pages | ID: I2D4DAC1EC3EEN
DataM Intelligence

US$ 2,999.00 US$ 4,350.00 -31 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Inflammation Supplement Market was valued at USD 9.8 billion in 2025 and is anticipated to reach USD 19.6 billion by 2033, at a CAGR of 0.079 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Inflammation Supplement Market.

This report delivers a comprehensive overview of the Inflammation Supplement Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inflammation Supplement Market. The Inflammation Supplement Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

Inflammation Supplement Market Scope:

By Ingredient
  • Lactobacillus
  • Bifidobacterium
  • Saccharomyces
  • Others
By Product Type
  • Dietary Supplements
  • Functional Foods and Beverages
By Form
  • Tablets
  • Capsules
  • Gummies
  • Powders
By Application
  • Digestive Health
  • Immune Health
  • Joint Health
  • Skin Health
  • Others
By End-User
  • Infants & Children
  • Adults
  • Middle-Aged
  • Elderly
By Distribution Channel
  • Supermarkets/Hypermarkets
  • Online Channel
  • Specialty Stores
  • Others
Key Players
  • Nestle S.A.
  • Procter & Gamble
  • Johnson & Johnson
  • Pfizer
  • Bayer
  • GlaxoSmithKline
  • Sanofi
  • Abbott Laboratories
  • DSM Nutritional Products
  • Danone
Major Highlights

This report delivers a comprehensive overview of the Inflammation Supplement Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inflammation Supplement Market. The Inflammation Supplement Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
  • Increase Your Customer Base by 3X using our Partner Identification tool
  • Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
  • Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
  • Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Ingredient
3.2. Snippet by Form
3.3. Snippet by Product Type
3.4. Snippet by Application
3.5. Snippet by End-User
3.6. Snippet by Distribution Channel
3.7. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Prevalence of Inflammatory Diseases
    4.1.1.2. Growing Demand for Natural and Preventive Healthcare Solutions
  4.1.2. Restraints
    4.1.2.1. Limited Awareness and Adoption in Developing Regions
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. BY INGREDIENT

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  6.1.2. Market Attractiveness Index, By Ingredient
6.2. Lactobacillus*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Bifidobacterium
6.4. Saccharomyces
6.5. Others

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Dietary Supplements*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  7.2.3. Multistrain Probiotics
  7.2.4. Single Strain Probiotics
  7.2.5. Prebiotic and Probiotic Combinations
  7.2.6. Synbiotics
7.3. Functional Foods and Beverages
  7.3.1. Probiotic Yogurt
  7.3.2. Probiotic Drinks
  7.3.3. Probiotic Snacks
  7.3.4. Fortified Cereals

8. BY FORM

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  8.1.2. Market Attractiveness Index, By Form
8.2. Tablets*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Gummies
8.5. Powders

9. BY APPLICATION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.1.2. Market Attractiveness Index, By Application
9.2. Digestive Health*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Immune Health
9.4. Joint Health
9.5. Skin Health
9.6. Others

10. BY END-USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.1.2. Market Attractiveness Index, By End-User
10.2. Infants & Children*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Adults
10.4. Middle-Aged
10.5. Elderly

11. BY DISTRIBUTION CHANNEL

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Supermarkets/Hypermarkets*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Online Channel
11.4. Specialty Stores
11.5. Others

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.9.1. U.S.
    12.2.9.2. Canada
    12.2.9.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.9.1. Germany
    12.3.9.2. UK
    12.3.9.3. France
    12.3.9.4. Italy
    12.3.9.5. Spain
    12.3.9.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.9.1. Brazil
    12.4.9.2. Argentina
    12.4.9.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.9.1. China
    12.5.9.2. India
    12.5.9.3. Japan
    12.5.9.4. Australia
    12.5.9.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

14.1. Nestl? S.A. *
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Financial Overview
  14.1.4. Key Developments
14.2. Procter & Gamble
14.3. Johnson & Johnson
14.4. Pfizer
14.5. Bayer
14.6. GlaxoSmithKline
14.7. Sanofi
14.8. Abbott Laboratories
14.9. DSM Nutritional Products
14.10. Danone (LIST NOT EXHAUSTIVE)

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us


More Publications